Literature DB >> 11115066

Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.

J Zimpelmann1, D Kumar, D Z Levine, G Wehbi, J D Imig, L G Navar, K D Burns.   

Abstract

BACKGROUND: Enhanced intrarenal angiotensin II (Ang II) activity may contribute to diabetic nephropathy. The proximal tubule is a proposed site of significant intrarenal Ang II production. We determined the effect of early diabetes on mRNA expression of components of the proximal tubule renin-angiotensin system.
METHODS: Three groups of male Sprague-Dawley rats were studied after two weeks: (1) control (C), (2) streptozotocin-induced diabetes (STZ), and (3) STZ-induced diabetes, with normoglycemia maintained by insulin implants (STZ-I). Competitive reverse transcription-polymerase chain reaction was used to assay mRNA for renin, angiotensinogen, and angiotensin-converting enzyme in suspensions of proximal tubules; plasma and kidney levels of Ang II were measured by radioimmunoassay, and Western analysis of Ang II subtype 1 (AT1) receptors was performed.
RESULTS: STZ rats tended to have increased plasma and intrarenal levels of Ang II compared with C and STZ-I rats. In proximal tubules, mRNA for renin was significantly increased in STZ rats, with reversal to control values in STZ-I rats (C, 2432 +/- 437 vs. STZ, 5688 +/- 890 fg/0.25 microg RNA, P < 0.05 vs. C, N = 9, vs. STZ-I, 1676 +/- 376 fg/0.25 microg RNA, P = NS vs. C). In STZ rats, the AT1 receptor antagonist losartan caused a further fivefold increase in proximal tubule renin mRNA, associated with proximal tubular renin immunostaining. STZ had no significant effect on mRNA expression for angiotensinogen or angiotensin-converting enzyme in proximal tubules. By Western blot analysis, cortical and proximal tubule AT1 receptor protein expression was significantly decreased in STZ rats.
CONCLUSIONS: These data suggest activation of the proximal tubule renin-angiotensin system in early STZ diabetes, mediated at least partly by enhanced expression of renin mRNA. Increased local production of Ang II could contribute to tubulointerstitial injury in this model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115066     DOI: 10.1046/j.1523-1755.2000.00416.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  36 in total

Review 1.  Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise.

Authors:  Boutros El-Haddad; Scott Reule; Paul E Drawz
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.

Authors:  Masahiro Eriguchi; Mercury Lin; Michifumi Yamashita; Tuantuan V Zhao; Zakir Khan; Ellen A Bernstein; Susan B Gurley; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

3.  Exercise training improves the defective centrally mediated erectile responses in rats with type I diabetes.

Authors:  Hong Zheng; William G Mayhan; Kaushik P Patel
Journal:  J Sex Med       Date:  2011-08-24       Impact factor: 3.802

4.  Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.

Authors:  Liliya M Yamaleyeva; Shea Gilliam-Davis; Igor Almeida; K Bridget Brosnihan; Sarah H Lindsey; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-29

5.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 6.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

7.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?

Authors:  Andrea Fekete; Klara Rosta; Laszlo Wagner; Agnes Prokai; Peter Degrell; Eva Ruzicska; Edit Vegh; Miklos Toth; Katalin Ronai; Krisztina Rusai; Aniko Somogyi; Tivadar Tulassay; Attila J Szabo; Agota Ver
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

9.  Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells.

Authors:  Ebaa M Alzayadneh; Mark C Chappell
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-06-24       Impact factor: 1.636

10.  Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.

Authors:  Yan Zhang; Dilip K Deb; Juan Kong; Gang Ning; Yurong Wang; George Li; Yunzi Chen; Zhongyi Zhang; Stephen Strugnell; Yves Sabbagh; Cynthia Arbeeny; Yan Chun Li
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.